Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

The quadrivalent vaccine significantly reduced the incidence of HPV-associated anogenital diseases in young women. (ClinicalTrials.gov number, NCT00092521 [ClinicalTrials.gov].).